AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
Molecular pathology of pancreatic cancer
Authors: Hruban, RH Iacobuzio-Donahue, C Wilentz, RE Goggins, M Kern, SE
Citation: Rh. Hruban et al., Molecular pathology of pancreatic cancer, CANCER J, 7(4), 2001, pp. 251-258
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer
Authors: Tersmette, AC Petersen, GM Offerhaus, GJA Falatko, FC Brune, KA Goggins, M Rozenblum, E Wilentz, RE Yeo, CJ Cameron, JL Kern, SE Hruban, RH
Citation: Ac. Tersmette et al., Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer, CLIN CANC R, 7(3), 2001, pp. 738-744
Frequent germline deletion polymorphism of chromosomal region 8p12-p21 identified as a recurrent homozygous deletion in human tumors
Authors: Ryu, B Song, J Sohn, T Hruban, RH Kern, SE
Citation: B. Ryu et al., Frequent germline deletion polymorphism of chromosomal region 8p12-p21 identified as a recurrent homozygous deletion in human tumors, GENOMICS, 72(1), 2001, pp. 108-112
Impact of the initial doses of rocuronium and pancuronium on subsequent maintenance for neuromuscular block
Authors: Kern, SE Fragen, RJ Fitzgerald, PC van Zeeland, M Johnson, JO
Citation: Se. Kern et al., Impact of the initial doses of rocuronium and pancuronium on subsequent maintenance for neuromuscular block, CAN J ANAES, 48(2), 2001, pp. 129-132
Pancreatic intraepithelial neoplasia - A new nomenclature and classification system for pancreatic duct lesions
Authors: Hruban, RH Adsay, NV Albores-Saavedra, J Compton, C Garrett, ES Goodman, SN Kern, SE Klimstra, DS Kloppel, G Longnecker, DS Luttges, J Offerhaus, GJA
Citation: Rh. Hruban et al., Pancreatic intraepithelial neoplasia - A new nomenclature and classification system for pancreatic duct lesions, AM J SURG P, 25(5), 2001, pp. 579-586
Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: Analysis of progression and recurrence by DPC4 immunohistochemical labeling
Authors: McCarthy, DM Brat, DJ Wilentz, RE Yeo, CJ Cameron, JL Kern, SE Hruban, RH
Citation: Dm. Mccarthy et al., Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: Analysis of progression and recurrence by DPC4 immunohistochemical labeling, HUMAN PATH, 32(6), 2001, pp. 638-642
ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma
Authors: Su, GH Bansal, R Murphy, KM Montgomery, E Yeo, CJ Hruban, RH Kern, SE
Citation: Gh. Su et al., ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma, P NAS US, 98(6), 2001, pp. 3254-3257
Invasion-specific genes in malignancy: Serial analysis of gene expression comparisons of primary and passaged cancers
Authors: Ryu, B Jones, J Hollingsworth, MA Hruban, RH Kern, SE
Citation: B. Ryu et al., Invasion-specific genes in malignancy: Serial analysis of gene expression comparisons of primary and passaged cancers, CANCER RES, 61(5), 2001, pp. 1833-1838
Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations
Authors: Jones, JB Song, JJ Hempen, PM Parmigiani, G Hruban, RH Kern, SE
Citation: Jb. Jones et al., Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations, CANCER RES, 61(4), 2001, pp. 1299-1304
Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
Authors: Argani, P Rosty, C Reiter, RE Wilentz, RE Murugesan, SR Leach, SD Ryu, BW Skinner, HG Goggins, M Jaffee, EM Yeo, CJ Cameron, JL Kern, SE Hruban, RH
Citation: P. Argani et al., Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma, CANCER RES, 61(11), 2001, pp. 4320-4324
Differing rates of loss of Dpc4 expression and of p53 overexpression amongcarcinomas of the proximal and distal bile ducts - Evidence for biologic distinction
Authors: Argani, P Shaukat, A Kaushal, M Wilentz, RE Su, GH Sohn, TA Yeo, GJ Cameron, JL Kern, SE Hruban, RH
Citation: P. Argani et al., Differing rates of loss of Dpc4 expression and of p53 overexpression amongcarcinomas of the proximal and distal bile ducts - Evidence for biologic distinction, CANCER, 91(7), 2001, pp. 1332-1341
High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells
Authors: Sohn, TA Su, GH Ryu, B Yeo, CJ Kern, SE
Citation: Ta. Sohn et al., High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells, ANN SURG, 233(5), 2001, pp. 696-702
Influence of hemorrhagic shock on remifentanil - A pharmacokinetic and pharmacodynamic analysis
Authors: Johnson, KB Kern, SE Hamber, EA McJames, SW Kohnstamm, KM Egan, TD
Citation: Kb. Johnson et al., Influence of hemorrhagic shock on remifentanil - A pharmacokinetic and pharmacodynamic analysis, ANESTHESIOL, 94(2), 2001, pp. 322-332
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects
Authors: Montgomery, E Goggins, M Zhou, SB Argani, P Wilentz, RE Kaushal, M Booker, S Romans, K Bhargava, P Hruban, RH Kern, SE
Citation: E. Montgomery et al., Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects, AM J PATH, 158(2), 2001, pp. 537-542
Progression model for pancreatic cancer
Authors: Hruban, RH Goggins, M Parsons, J Kern, SE
Citation: Rh. Hruban et al., Progression model for pancreatic cancer, CLIN CANC R, 6(8), 2000, pp. 2969-2972
Immunohistochemical p16(INK4a) analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene - A comparison of fourcommercial antibodies
Authors: Geradts, J Hruban, RH Schutte, M Kern, SE Maynard, R
Citation: J. Geradts et al., Immunohistochemical p16(INK4a) analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene - A comparison of fourcommercial antibodies, APPL IMMUNO, 8(1), 2000, pp. 71-79
Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subsetof pancreatic and biliary cancers
Authors: Hilgers, W Song, JJ Haye, M Hruban, RR Kern, SE Fearon, ER
Citation: W. Hilgers et al., Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subsetof pancreatic and biliary cancers, GENE CHROM, 27(4), 2000, pp. 353-357
Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas
Authors: Hilgers, W Koerkamp, BG Geradts, J Tang, DJ Yeo, CJ Hruban, RH Kern, SE
Citation: W. Hilgers et al., Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas, GENE CHROM, 27(3), 2000, pp. 239-243
Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4
Authors: Jones, JB Kern, SE
Citation: Jb. Jones et Se. Kern, Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4, NUCL ACID R, 28(12), 2000, pp. 2363-2368
Molecular genetics of ductal pancreatic neoplasia
Authors: Su, GH Kern, SE
Citation: Gh. Su et Se. Kern, Molecular genetics of ductal pancreatic neoplasia, CURR OPIN G, 16(5), 2000, pp. 419-425
Dpc4 protein in mucinous cystic neoplasms of the pancreas - Frequent loss of expression in invasive carcinomas suggests a role in genetic progression
Authors: Iacobuzio-Donahue, CA Wilentz, RE Argani, P Yeo, CJ Cameron, JL Kern, SE Hruban, RH
Citation: Ca. Iacobuzio-donahue et al., Dpc4 protein in mucinous cystic neoplasms of the pancreas - Frequent loss of expression in invasive carcinomas suggests a role in genetic progression, AM J SURG P, 24(11), 2000, pp. 1544-1548
Molecular genetic alterations in ductal pancreatic adenocarcinomas
Authors: Kern, SE
Citation: Se. Kern, Molecular genetic alterations in ductal pancreatic adenocarcinomas, MED CLIN NA, 84(3), 2000, pp. 691
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families
Authors: Lynch, HT Brand, RE Lynch, JF Fusaro, RM Smyrk, TC Goggins, M Kern, SE
Citation: Ht. Lynch et al., Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families, GASTROENTY, 119(6), 2000, pp. 1756-1760
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
Authors: Wilentz, RE Iacobuzio-Donahue, CA Argani, P McCarthy, DM Parsons, JL Yeo, CJ Kern, SE Hruban, RH
Citation: Re. Wilentz et al., Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression, CANCER RES, 60(7), 2000, pp. 2002-2006
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library
Authors: Su, GH Sohn, TA Ryu, B Kern, SE
Citation: Gh. Su et al., A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library, CANCER RES, 60(12), 2000, pp. 3137-3142
Risultati: 1-25 | 26-45